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ABSTRACT

Mycoplasma Pneumoniae: Analysis of Metabolic Pathways in a Minimal
Genome (December 2019)
Maria G. Hinojosa-Salinas, B.S., The University of Texas at San Antonio
Chair of Committee: Dr. Daniel J. Mott

Mycoplasma pneumoniae, a bacterium lacking a cell wall, is one of the main
causative agents of atypical pneumonia and contributes to the development of
chronic respiratory disease. This organism has undergone reductive evolution and
relies on the human host for the acquisition of most nutrients. Around 33% of M.
pneumoniae proteins are of unknown function. The aim of my research was to grow
this organism in various carbon sources and media to understand which metabolic
pathways could be present in this minimal organism. Twenty-seven carbon sources
and seven different media were tested. The results show that glucose, maltose, and
dextrin caused significant growth of M. pneumoniae. The genes involved in glucose
metabolism have been found, however, the genes involved in maltose and dextrin
metabolism within this organism have not. The media growth experiment showed
that Mueller Hinton II broth caused significantly reduced growth of this organism.
Knowing which carbon sources can be utilized by M. pneumoniae will help us
understand the metabolic pathways in this minimal organism. Novel metabolic
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pathways within M. pneumoniae can ultimately help us find potential targets for
antibiotics or vaccines.
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INTRODUCTION
Manifestation of Infection
Mycoplasma pneumoniae is a pathogenic organism which colonizes the lung
epithelia in the human host causing different respiratory disorders. About 2 million M.
pneumoniae infection cases occur in the United States every year [1]. The route of
transmission for this microbe is from person to person via respiratory droplets.
Infected individuals can develop tracheobronchitis, a form of lower respiratory tract
infection, as well as atypical pneumonia. The CDC describes atypical pneumonia as
infections which have different symptoms and show different response to treatments
used for typical pneumonia. In addition, M. pneumoniae is known to exacerbate prior
respiratory conditions such as asthma, and can lead to extrapulmonary
complications such as stroke or encephalitis in highly developed infections [2, 3].
Characteristics of M. pneumoniae
Mycoplasma pneumoniae possesses a small genome of about 816 kbp which
is why this bacterium is considered a minimal organism. All minimal organisms have
streamlined genomes retaining only the genes necessary for survival under specific
environmental conditions [4]. For example, M. pneumoniae depends on the nutrients
provided by the human host since it has lost many of its biosynthetic pathways (e.g.
amino acid synthesis) [5, 6]. Mycoplasma pneumoniae also lacks a cell wall
therefore making antibiotics that target cell wall synthesis ineffective [7]. Small
genomes along with reduced biosynthetic capacities makes Mycoplasma species a
valuable tool for understanding genes necessary for life. Around 33% of the M.
__________
This thesis follows the style of PLOS Biology.
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pneumoniae proteins are of unknown function making gene characterization crucial
[8]. Knowing which carbon sources M. pneumoniae can utilize will shed light on
which genes and biochemical pathways are present in this minimal organism.
It is hypothesized that M. pneumoniae contains several unexplored
biochemical pathways. This project will focus on growing M. pneumoniae with
different carbon sources and media to explore potential metabolic pathways used by
this organism. Proteins involved in these biochemical pathways can be potential
targets for antibiotics or vaccines.
Pathogenesis
Attachment to host cells is a requirement for virulence [9]. Mycoplasma
pneumoniae utilizes an apical attachment organ composed of P1 and P30 adhesins
along with other accessory adhesion proteins to bind to host cells. Individual cells
may attach to the lung epithelia via N-acetylneuraminic acid (sialic acid) expressed
on the host membrane but other host ligands such as sulfated glycolipids and
Surfactant Protein A have been implicated as well [10,11]. Attachment protects the
microbe from mucociliary clearance and concentrates the cytotoxic effects produced
[12].
The nature of many pathogens exhibits a direct link between carbon
metabolism and pathogenicity. Mycoplasma pneumoniae breaks down
phospholipids found in the host’s lung epithelia and utilizes them for energy.
Hydrogen peroxide, a major virulence factor, is produced from the breakdown of
these phospholipids. Hydrogen peroxide results in cellular damage to the host via
peroxidation of lipids which can eventually cause lysis of the host cell. Indeed in
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many species of the genus Mycoplasma metabolism of phospholipid components,
namely glycerol and glycerophosphocholine, produce cytotoxicity caused by
hydrogen peroxide production [13].
In addition to hydrogen peroxide, the community-acquired respiratory distress
syndrome (CARDS) toxin is an important virulence factor in M. pneumoniae. The
CARDS toxin contains a unique KELED (Lys-Glu-Leu-Glu-Asp) motif which is of vital
importance in its delivery to the host endoplasmic reticulum and subsequent host
cytotoxicity [14]. This toxin transfers an ADP-ribosyl group to host target proteins
producing vacuolization and eventual cell death [15]. The CARDS toxin is the only
known exotoxin in M. pneumoniae.
Another factor implicated in virulence is hydrogen sulfide, which is
responsible for host haemolysis [16]. Mycoplasma pneumoniae probably
synthesizes this virulence factor, via HapE, in order to acquire nutrients such as
amino acids and nucleotides. This is yet another multifunctional enzyme
encountered in this minimal organism. This enzyme might also be involved with the
synthesis of thiouridine in tRNA and/or might function to convert cysteine into
alanine [16]. Additionally, HapE may possess cysteine desulfhydrase activity which
converts cysteine into pyruvate; this is practical since the oxidation of pyruvate can
then produce one extra ATP [16].
Intracellular growth of bacteria within host cells allows evasion of the immune
system and may contribute to chronic lung disease. The internalization of
Mycoplasma within human cells was first documented in 1960 [17]. Mycoplasma
penetrans has been described as an invasive species while M. gallisepticum and M.
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fermentans have been shown to invade host cells under certain conditions [18–20].
Mycoplasma pneumoniae has been shown to survive within the human lung
carcinoma cell line (A549) for a prolonged period of time [21].
Regulatory Systems in M. pneumoniae
There have been few regulatory mechanisms identified in this organism. One
which has is the phosphotransferase system (PTS) which is used in the transport of
simple sugars. The phosphotransferase system is mainly used in the transport of
sugars (e.g. glucose and fructose) which are not commonly found in the lung
epithelia [22]. Recent studies have shown other potential regulatory mechanisms
involved in the metabolism of different carbon sources. Mycoplasma pneumoniae
utilizes phospholipids in the lung epithelia as its main source of energy [23]. Glycerol
and glycerophosphocholine (GPC), constituents of phospholipids, enter glycolysis as
dihydroxyacetone phosphate (DHAP). The metabolism of these molecules produces
hydrogen peroxide which acts as a major virulence factor in the human host [5].
Before GPC can enter glycolysis as DHAP its diester group is removed by the
glycerophosphodiesterase GlpQ (mpn20). The trigger enzyme GlpQ is an important
regulatory protein suggested to be involved in the control of gene expression
depending on the availability of glycerol-3-phosphate which is an intermediate in the
breakdown of glycerol and GPC [24]. Mutants with glpQ knockouts exhibit no H2O2
production in the presence of phosphatidylcholines and have reduced growth in the
presence of glucose [24].
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Regulators in Mycoplasma pneumoniae
One regulator of interest, mpn329, is part of the FUR (ferric uptake regulator)
superfamily. It is currently unknown whether in M. pneumoniae this protein acts as a
ferric uptake regulator specifically and/or as a FUR-like protein known as PerR
(peroxide regulator). The FUR regulates various genes contingent on the presence
or absence of iron. It can control the transport of iron, synthesis of siderophores, and
the expression of various proteins that utilize iron for their enzymatic function [25,
26]. The peroxide regulator mediates gene expression in response to the presence
of hydrogen peroxide. A PerR mutant in the organism Streptococcus pyogenes
displays decreased levels of virulence brought on by a change in intracellular iron
and oxide response [27]. This regulator could be vital in understanding the virulence
mechanisms in M. pneumoniae.
Another regulator, mpn239, is part of the GntR family of regulators which
respond to metabolites such as pyruvate, lactate, gluconate, and alkylphosphates
[28]. The most common sub-family, FadR, accounts for about 40% of GntR
regulators and is involved in fatty acid biosynthesis and degradation [29]. An
additional regulator of interest, mpn478, is found in the YebC family. Pseudomonas
aeruginosa encodes a YebC family protein, PA0964, which regulates phenazine
synthesis and the Pseudomonas quinolone signal system (PQS) [30]. Phenazine
and PQS are both involved in quorum sensing in this organism. These three
regulators have been identified in M. pneumoniae and are of special interest as they
may contribute to our understanding of the limited regulatory networks in this
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organism. In addition, the fact that some of these regulators are implicated in
virulence in other organisms makes their study crucial.
Phosphoproteome of Mycoplasma pneumoniae
Phosphorylation of proteins is a post-translational modification which alters a
protein's function [31]. A study on the phosphoproteome of M. pneumoniae found a
total of 63 phosphoproteins or 10% of total encoded proteins which exceeds the
percentage found in other bacteria [32]. Mycoplasma pneumoniae encodes two
kinases, HPrK and PrkC, which were found to phosphorylate 5 of the 63 proteins;
autophosphorylation and the possible existence of unknown kinases may be the
cause of these unexplained phosphorylation events [32]. A substantial number of
phosphorylated proteins found in this study dealt with adhesion to the host cells and
carbon metabolism. The proteins of the PTS have various phosphorylation states
depending on the availability of carbon sources [33]. The PTS protein, HPr, is
phosphorylated on Ser-46 by HPrK. This kinase exhibits higher activity when
glycerol rather than glucose is used as a carbon source suggesting glycerol
metabolism requires more regulation [34].
Virulence caused by M. pneumoniae is not only triggered by the catabolism of
carbon sources but also by adhesion to host epithelial cells [12, 35]. Mycoplasma
pneumoniae forms an attachment organelle composed of various adhesins and
proteins involved with structural stabilization of the organelle [36]. A study has
shown these proteins can be regulated through phosphorylation by the kinase PrkC
[37]. Mutants with a defunct prkC are unable to cause toxicity to host cells as they
are unable to adhere properly [37].
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Evolution of Reduced Genomes
Mycoplasma pneumoniae belongs to the Mollicute class which is believed to
have diverged from a Streptococcus branch of gram-positive bacteria about 605
million years ago [12]. Mycoplasma pneumoniae has a reduced (minimal) genome
with low GC-content. Organisms with reduced genomes need stable environments
and tend to rely on eukaryotic hosts while those with large genomes are free-living
and have versatile lifestyles.
Bacterial genomes are biased towards deletions [38, 39]. Proposed
advantages for genome reduction include a reduction in nutrients used and energy
needed for DNA synthesis along with more cell space for the cell's other functions
[40]. Bacteria with reduced genomes evolve from free-living ancestors. The reduced
genomes are thought to occur as a result of mobile element-mediated
rearrangements within the chromosome and subsequent deletions [41, 42]. Nonessential genes may be lost as the selective pressures to maintain them are reduced
in the host. In addition, there is a decreased efficiency in selectively removing
deleterious alleles from the population due to reduced competition within the small
population size; this will lead to inactivation of genes through genetic drift [42].
Metabolic Pathways in M. pneumoniae
Glycolysis
Mycoplasma pneumoniae produces most of its energy via glycolysis which is
the only fully functional central metabolic pathway. Proteins within the glycolytic
pathway of this organism can form a multiprotein complex [43]. These complexes
have been observed in some organisms and are believed to increase metabolic
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efficiency [44–47]. Some of the enzymes within this pathway have multiple roles. For
example, glycolytic kinases can also phosphorylate nucleotides which is a function
usually performed by nucleoside diphosphate kinase [43]. In addition, some
glycolytic proteins are placed on the cell’s surface where they will bind to different
host factors such as plasminogen [48]. When plasminogen is bound by glycolytic
microbial proteins it activates into serine protease plasmin which degrades matrix
proteins; it is believed that these reactions are important in spreading bacteria
throughout host tissues [48, 49].
Pyruvate Metabolism
Mycoplasma pneumoniae may also produce energy by metabolizing pyruvate
into acetate. Pyruvate can also be reduced into lactate and, in turn, oxidize NADH
into NAD+. This organism contains a defunct citric acid cycle and electron transport
chain [50].
Pentose Phosphate Pathway
Many studies and reviews describe the pentose phosphate pathway as
incomplete in M. pneumoniae or Mycoplasmas in general [43, 51, 52, 53]. The
oxidative portion of this pathway is missing; however, the truncated pathway is
capable of generating phosphoribosyl pyrophosphate (PRPP) which provides a
sugar group that can be utilized in making nucleotides [32]. One study supplied this
organism with ¹³C₆ -labeled glucose and found that some pools of ribose 5phosphate were fully labeled within the cell indicating a flux from glycolysis to the
pentose phosphate pathway [50]. This same study suggests this pathway may also
help M. pneumoniae adapt to stressful conditions by providing a rescue route [50].
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Fatty Acid Metabolism
Fatty acid molecules must be provided in the media for proper growth since
M. pneumoniae is not capable of synthesizing most fatty acids [54]. Current research
shows that M. pneumoniae can synthesize three glycolipids, five phosphoglycolipids,
and six phospholipids [54]. Different glycolipids in this bacterium serve as important
antigens in early infection [54]. The intermediate in glycerol or
glycerophosphocholine breakdown, glycerol 3-phosphate, can enter either glycolysis
as DHAP or fatty acid metabolism as phophatidylglycerol which can then be
converted into different glycolipids [53].
Nucleotide Metabolism
Nucleotide biosynthesis depends on the acquisition of certain nucleotide
precursors (e.g. nucleosides, deoxynucleosides, bases) from the host since this
bacterium is not capable of synthesizing pyrimidines and purines de novo [55].
Thymidine 5-triphosphate (dTTP) is created, for example, via the substrates uracil or
thymine [56]. Thymidine phosphorylase (TP) catalyzes the attachment of a
deoxyribose group to uracil or thymine resulting in deoxyuridine (dU) and thymidine
(dT), respectively [56]. Thymidine kinase can then transfer a phosphate group from
ATP to dT or dU creating thymidine 5’-monophosphate (dTMP) or deoxyuridine 5’monophosphate (dUMP), respectively [56]. Then thymidylate synthase (TS)
transfers a methyl group from methylenetetrahydrofolate to dUMP which produces
dTMP [56]. Thymidine 5’-monophosphate is, therefore, produced from either
pathway and connects them. At this point thymidylate kinase (TMDK) will transfer a
phosphate group from ATP to dTMP resulting in thymidine 5’-diphosphate (dTDP)
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[56]. The last reaction involves either TMPK or pyruvate kinase transferring a
phosphate group to dTDP in order to produce dTTP [56]. There are additional
enzymes within the dTTP synthesis pathway that are yet to be discovered since a
thyA (TS) mutant is still able to metabolize dU and lead to dTTP synthesis [56].
The results of one study led to the conclusion that M. pneumoniae duplicates
slowly (6 hours) due to the inefficient synthesis of thymidine 5-triphosphate [56, 57].
Utilizing thymine instead of UMP as a precursor to dTTP would result in faster
growth [58]. This study determined that the expression of thymidine phosphorylase
was influenced by the nutritional complexity of the media; when a minimal medium
was utilized the organism was not able to convert deoxyuridine or thymidine to their
respective bases (i.e. remove the pentose sugar group) and/or salvage thymine [54,
56]. In addition, the researchers in this study surmised that transporters are
probably specific for different kinds of bases, deoxynucleosides, and ribonucleosides
since they showed that some nucleotide precursors were taken up and metabolized
by the bacterium (e.g. thymine, thymidine, uracil) but some were not (e.g.
deoxyuridine) [56].
Nucleotide metabolism has been of special interest in drug development.
Nucleoside analogs have been proposed as a potentially effective method of
inhibiting DNA or RNA synthesis [59]. Indeed one study has observed growth
inhibition of M. pneumoniae when testing different nucleoside and nucleobase
analogs utilized in antiviral and anticancer therapy [60]. However, these analogs
have a narrow therapeutic index and therefore are not suitable against bacterial
infections [60]. Nucleoside analog based antibiotics are being developed which
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focus on the structural differences between target enzymes of the bacteria and host
and, therefore, will increase the specificity to the bacterial target [60].
Carbon sources previously tested in M. pneumoniae
Different studies have looked at potential carbon sources for M. pneumoniae.
One study looked at growth assays of this organism when grown in glucose,
fructose, mannitol, or glycerol as potential carbon sources [34]. The four carbon
sources are involved in the glycolysis pathway. Wet weight analysis determined M.
pneumoniae is able to utilize all these carbon sources except for mannitol even
though all genes necessary for its utilization appear to be present [34, 61]. A
different study determined a positive growth effect on the organism produced by
mannose, ascorbate, and ribose [62]. The effects of rhamnose on M. pneumoniae
have not been tested, but one study suggests that Mycoplasmas are not able to
procure rhamnose from the lung environment since humans do not synthesize it
[63]. Xylose, maltose, starch, and dextrin can be fermented by this organism [64,
65]. As mentioned previously, M. pneumoniae is able to utilize
glycerophosphocholine creating hydrogen peroxide in the process.
The objective of this project is to cultivate M. pneumoniae in different carbon
sources and media in order to analyze growth. Knowing which carbon sources can
be utilized by M. pneumoniae will help us understand the metabolic pathways in this
organism which can include potential targets for antibiotics or vaccines.
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METHODS
Growth in Media
Mycoplasma species are ubiquitous contaminants of different cell lines
growing in different types of media [66]. They have been shown to alter their cell
membrane and size depending on the composition of the media in which they are
grown [66]. Therefore, M. pneumoniae can grow and adapt to the different media
available. Growth properties of M. pneumoniae in different media were tested.
Mycoplasma pneumoniae is generally grown in either SP4 or Hayflick media,
however by testing different unconventional media we shall obtain a better
understanding of this organism’s ability to utilize different nutrients. Growth curves
were determined by optical density via a spectrophotometer as opposed to
colorimetric analysis used by another group; which will yield better quantitative data
and facilitate comparisons between different media [50].
The doubling time of these bacteria is 6 hours which is rather slow and the
stationary phase is not reached until day 6. Mycoplasma pneumoniae was grown in
different media and harvested every 2 days for a total of 6 days. These conditions
were tested with and without glucose. All optical density measurements were
measured at a wavelength of 550 nm. The optical density of frozen cultures was
measured to ensure equal inoculation of starting cultures. A passage is a subculture
that has started from a previous culture with the first passage starting from the
reference strain. In addition, each starting culture only utilized organisms frozen in
their 5th passage to reduce variability between cultures; this passage number was
chosen as the lab standard for commencing experiments. Graphpad Prism software
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was used to visualize the different growth curves. Each starting culture was
inoculated with a volume of cells which had an experimentally determined starting
OD550 of 0.001 abs. This ensures that the smallest number of cells were used for
inoculation while still retaining similar growth outputs as cultures started with higher
optical densities. The formula below was used to determine the volume of cells to
add to the starting culture:
Final volume of starting cell culture (33,300 uL or 36,300 uL) * OD550 (i.e.
0.001) = Volume of cell culture from cryogenic tube (X uL) * OD550 (measured *2)
Each flask (25 cm3) contained 8 mL of media and 2 mL of horse serum (~20
% of total). In addition, 100 uL of penicillin (100,000 U/mL) and 200 uL of glucose (~
2% of total) were added to the starting cultures. Penicillin was added in order to
prevent growth of unwanted bacteria and since it would not affect the growth of this
particular organism since its mode of action affects cell wall synthesis. Six different
unconventional media were selected. The media were as follows: Lysogeny Broth,
Nutrient Broth, Tryptic Soy Broth, Mueller Hinton II Broth, Bacto Brain Infusion, and
Dulbecco’s Modified Eagle’s Medium. These media were chosen based on how
accessible and ubiquitous they are in the microbiology laboratory setting. In addition,
DMEM, a medium used to grow mammalian cell cultures, was chosen to expand the
range of media types to be tested. The components of DMEM can be seen in Table
1. No research has been done with cultivation of M. pneumoniae using these
unconventional types of media.
The next steps involved harvesting the cells for spectrophotometer
measurement. Culture flasks were utilized to increase the surface area our organism
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was exposed to since these bacteria grow attached to a surface. Old media and
waste products were removed by washing the cells thrice with PBS. The cells were
scraped off, diluted with 1 mL of PBS and centrifuged for 5 minutes (10,000 x g and
4°C). The cells adhered to culture flasks so in order to dislodge them a sterile
scraper with a rubber head was used. After discarding the supernatant, the pellet
was resuspended in 1 mL of PBS. Then 800 uL of the cell and PBS suspension was
transferred to the spectrophotometer cuvette for measurement. The
spectrophotometer was blanked with PBS. The actual concentration of cells was
obtained by dividing the measured absorbance by 10.
Growth with Carbon Sources
In addition to different media, M. pneumoniae was grown in different carbon
sources. The standard media used was modified Hayflick. The modified Hayflick
media contains: Difco PPLO broth, HEPES, phenol red, and NaOH [67]. The Difco
PPLO broth itself contains beef heart infusion, peptones, yeast extract, and NaCl.
The BD Bionutrients technical manual states that beef infusions contain peptides,
amino acids, nucleotide fractions, organic acids, minerals, and some vitamins. In
addition, the BD Bionutrients technical manual states that yeast extract supplies
diphosphopyridine nucleotides, proteins, carbohydrates, vitamins and micronutrients.
Peptone contains a mixture of peptides and amino acids [68]. Due to the fastidious
nature of this organism, a rich complex media is necessary for growth. The media
provides many carbon sources which were not removed for these growth
experiments. Growth was compared to a control which has no added carbon-source.

15

All carbon sources were filter-sterilized prior to inoculation. The carbon
sources have different solubilities; therefore, a standard 10% solution was assigned
for all. Twenty-seven carbon sources from different groups were tested. Each flask
contained 1 mL of 10% carbon source addition to the media, horse serum, and
penicillin. The final concentration of the carbon source in the culture flask was 0.9 %
for the 10% carbon source.
Statistical analyses
All statistical analyses were conducted with the computing software R for
each 2 day increment. The significance threshold of the p-value was set at .05.
Single-factor ANOVA was used to determine if any significant difference existed
among the means of the groups tested. The null hypothesis for this test is that the
means are the same for all groups. However, in the end, a different test was utilized
since the data violated assumptions needed for ANOVA. The first assumption the
data failed was the assumption of homogeneity of variance. The Bartlett’s test was
used to determine whether the different groups had equal variances. In addition, the
assumption of normality was violated for ANOVA. This was determined by the
Shapiro-Wilk Test for Normality. Instead of using ANOVA the Kruskal-Wallis H test
was utilized. This test does not assume normality or homogeneity of variances. With
this non-parametric test it was determined whether the samples came from the same
distribution.
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RESULTS
Carbon Sources
A total of 27 different carbon sources were tested on M. pneumoniae M129B7. Growth curves were created via GraphPad Prism. Each point is the
corresponding average O.D. value for the day while bars emanating from the points
represent error bars which show the deviation from the average point. The optical
density of the control bacterial population grew 460% between day 0 and day 6. The
carbon sources were grouped by their chemical composition (e.g. alcohol sugar,
sugar acid, polysaccharides, etc). The Bartlett’s test and Shapiro-Wilk’s test
determined the carbon source data did not have homogeneity of variances or follow
a normal distribution (Table 1 and 2). The Kruskal-Wallis then determined the data
came from different distributions (Table 3). Dunn’s many-to-one determined where
the differences among the carbon sources occurred (Table 4).

Control
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Fig. 1 Alcohol sugar growth curve. Statistical analysis showed that glycerol
and mannitol were not significantly different from the control. The Kruskal–Wallis
tests detected significant differences among the different groups for days
2 (χ2 = 78.216, df = 27, P < 0.00001), 4 (χ2 = 68.984, df = 8, P < 0.0001), and 6
(χ2 = 78.216, df = 27, P < 0.00001).
Alcohol sugars are polyhydric alcohols which contain 3 or more hydroxyl
groups which are usually identified by the “-ol” ending. Glycerol, as mentioned
previously, is a constituent of host phospholipids that is metabolized by this
organism and produces hydrogen peroxide as a result. Statistical analysis, however,
did not show that glycerol or mannitol were significantly different from the control
(Figure 1). Dunn’s many-to-one for glycerol (p=0.1849, 0.2025, 0.1849) and mannitol
(p=1, 1, 1) on day 2, 4, and 6, respectively. The optical density of the glycerol and
mannitol bacterial populations between days 0 and 6 grew 1587% and 680%,
respectively.

Control
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Fig. 2 Amino acid growth curve. Statistical analysis showed that casamino acids
were not significantly different from the control. The Kruskal–Wallis tests detected
significant differences among the different groups for days
2 (χ2 = 78.216, df = 27, P < 0.00001), 4 (χ2 = 68.984, df = 8, P < 0.0001), and 6
(χ2 = 78.216, df = 27, P < 0.00001).
Casamino acids are the product of the treatment of casein (dairy protein)
which produces various hydrolysates. These hydrolysates are deficient in tryptophan
which are destroyed by the acid treatment used to produce the hydrolysates.
Statistical analysis showed that casamino acids were not significantly different from
the control. Dunn’s many-to-one test for casamino acids (p= 1, 1, 1) for days 2, 4,
and 6. The optical density of the casamino acid bacterial population between days 0
and 6 grew 477% (Figure 2).

Control
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Fig. 3 Amino sugars growth curve. Statistical analysis showed that sialic acid, Nacetyl-glucosamine, and glucosamine were not significantly different from the
control. The Kruskal–Wallis tests detected significant differences among the different
groups for days 2 (χ2 = 78.216, df = 27, P < 0.00001), 4
(χ2 = 68.984, df = 8, P < 0.0001), and 6 (χ2 = 78.216, df = 27, P < 0.00001).
Amino sugars are monosaccharides in which a hydroxyl group is replaced by
an amine group. Sialic acids are expressed on the host membrane and are
important in the attachment of M. pneumoniae. N-acetyl-glucosamine is a
component of hyaluronic acid and keratin sulfate [69]. Glucosamine, in humans, is
synthesized from glucose and is important in the creation of cartilage [70]. The dip in
day 2 for glucosamine is probably caused by human error during harvesting of cells
(Figure 3). Statistical analysis showed that sialic acid, N-acetyl-glucosamine, and
glucosamine were not significantly different from the control. Dunn’s many-to-one for
NAG (p=1, 1, 1), GlcN (p=1, 1, 1), and sialic acid (p=1, 1, 1) on day 2, 4, and 6,
respectively. The optical density of the NAG, GlcN, and sialic acid bacterial
populations between days 0 and 6 grew 750%, 97%, and 650%, respectively.
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Control

Fig. 4 Disaccharide growth curve. Maltose was the only carbon source from this
group to be significantly different from the control. The Kruskal–Wallis tests detected
significant differences among the different groups for days
2 (χ2 = 78.216, df = 27, P < 0.00001), 4 (χ2 = 68.984, df = 8, P < 0.0001), and 6
(χ2 = 78.216, df = 27, P < 0.00001).
Disaccharides are composed of two monosaccharides attached by a
glycosidic bond (Figure 4). Statistical analysis showed that cellobiose, lactose,
lactulose, sucrose, and trehalose were not significantly different from the control.
Dunn’s many-to-one for cellobiose (p= 0.5209, 0.4388, 0.5209), lactose (p=1, 1, 1),
lactulose (p=1, 1, 1), sucrose (p= 0.2138, 0.6370, 0.2138), and trehalose (p= 0.9194,
1, 0.9194) on day 2, 4, and 6, respectively. The optical density of the cellobiose,
lactose, lactulose, sucrose, and trehalose bacterial populations between days 0 and
6 grew 1187%, 720%, 957%, 1530%, and 1047%, respectively. Maltose was the

21

only carbon source from this group to be significantly different from the control.
Dunn’s many-to-one for maltose (p= 0.0095, 0.0213, 0.0095) on day 2, 4, and 6.
The optical density of the maltose bacterial population between day 0 and 6 grew
7730%.

Control

Fig. 5 Hexose growth curve. Glucose was the only carbon source from this group to
be significantly different from the control. The Kruskal–Wallis tests detected
significant differences among the different groups for days
2 (χ2 = 78.216, df = 27, P < 0.00001), 4 (χ2 = 68.984, df = 8, P < 0.0001), and 6
(χ2 = 78.216, df = 27, P < 0.00001).
Hexoses are simple sugars which contain six attached carbon and oxygen
atoms (Figure 5). Dunn’s many-to-one test for fructose (p= 0.4941, 0.5912, 0.4941),
mannose (p= 0.0950, 1, 0.0950), rhamnose (p=1, 1, 1), sorbose (p=1, 1, 1), fucose
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(p=1, 1, 1), and galactose (p=1, 1, 1) on days 2, 4, and 6, respectively. The optical
density of the fructose, mannose, rhamnose, sorbose, fucose, and galactose
bacterial populations between days 0 and 6 grew 1297%, 2020%, 600%, 534%,
440%, and 550%, respectively. Glucose was the only carbon source from this group
to be significantly different from the control. Dunn’s many-to-one test for glucose (p=
0.0161, 0.0350, 0.0161) on days 2, 4, and 6, respectively. The optical density of
glucose bacterial population between days 0 and 6 grew 6597%. These results
make sense since the preferred carbon source for most bacteria is glucose.

Control

Fig. 6 Pentose growth curve. Statistical analysis showed that arabinose, xylose, and
ribose were not significantly different from the control. The Kruskal–Wallis tests
detected significant differences among the different groups for days

23

2 (χ2 = 78.216, df = 27, P < 0.00001), 4 (χ2 = 68.984, df = 8, P < 0.0001), and 6
(χ2 = 78.216, df = 27, P < 0.00001).
Pentoses are simple sugars which contain five attached carbon atoms.
Statistical analysis showed that arabinose, xylose, and ribose were not significantly
different from the control (Figure 6). Dunn’s many-to-one test for arabinose (p=1, 1,
1), xylose (p=1, 1, 1), and ribose (p=1, 1, 1) for days 2, 4, and 6, respectively. The
optical density of the arabinose, xylose, and ribose bacterial populations between
days 0 and 6 grew 794%, 897%, and 580%, respectively.

Control

Fig. 7 Polysaccharide growth curve. Dextrin was the only carbon source from this
group to be significantly different from the control (only day 2 and 6). The Kruskal–
Wallis tests detected significant differences among the different groups for days
2 (χ2 = 78.216, df = 27, P < 0.00001), 4 (χ2 = 68.984, df = 8, P < 0.0001), and 6
(χ2 = 78.216, df = 27, P < 0.00001).
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Polysaccharides are composed of long chains of monosaccharides linked by
glycosidic bonds (Figure 7). Dunn’s many-to-one test for starch (p=0.0511, 0.0783,
0.0511) for day 2, 4, and 6, respectively. The optical density of the starch bacterial
population between days 0 and 6 grew 2680%. Dextrin was the only carbon source
from this group to be significantly different from the control (only day 2 and 6).
Dunn’s many-to-one test for dextrin (p=0.0282, 0.3671, 0.0282) for day 2, 4, and 6,
respectively. The optical density of the dextrin bacterial population between days 0
and 6 grew 3324%.The p-value for starch on day 6 is very close (p= 0.0511) to the
set threshold of .05 and if the threshold was less stringent this carbon source would
be considered significantly different to the control.

Control

Fig. 8 Sugar Acid growth curve. Statistical analysis showed that ascorbic acid and
gluconic acid were not significantly different from the control. The Kruskal–Wallis
tests detected significant differences among the different groups for days
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2 (χ2 = 78.216, df = 27, P < 0.00001), 4 (χ2 = 68.984, df = 8, P < 0.0001), and 6
(χ2 = 78.216, df = 27, P < 0.00001).
Sugar acids are monosaccharides that contain a carboxyl group (R–COOH)
at one or both ends of the chain [71]. Statistical analysis showed that ascorbic acid
and gluconic acid were not significantly different from the control. Dunn’s many-toone test for ascorbic acid (p=0.0646, 0.1244, 0.0646) and gluconic acid (p=1, 1, 1)
for days 2, 4, and 6, respectively. The optical density of the ascorbic acid and
gluconic acid bacterial populations between days 0 and 6 grew 2334%, and 537%,
respectively (Figure 8). A notable observation in the experiment revealed a dull,
chalky cell pellet when ascorbic acid was used as opposed to glossy and mucoid
one, which was seen in all other conditions when scraped cells were centrifuged. In
addition, usually the cell pellets were hard to resuspend but the cells grown with
ascorbic acid would resuspend with ease.

Control
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Fig. 9 Trisaccharide growth curve. Statistical analysis showed that raffinose was not
significantly different from the control. The Kruskal–Wallis tests detected significant
differences among the different groups for days
2 (χ2 = 78.216, df = 27, P < 0.00001), 4 (χ2 = 68.984, df = 8, P < 0.0001), and 6
(χ2 = 78.216, df = 27, P < 0.00001).
Trisaccharides are composed of three monosaccharides linked by glycosidic
bonds. Statistical analysis showed that raffinose was not significantly different from
the control. Dunn’s many-to-one test for raffinose (p= 1, 1, 1) for days 2, 4, and 6.
The optical density of the raffinose bacterial population between days 0 and 6 grew
1094%.
Table 1 Bartlett test of homogeneity of variances for days measured (carbon
sources). As can be seen by the p-values in Table 1 the null hypothesis of the
Bartlett’s test, that the samples have equal variances, was rejected for all 3 day
intervals.
Day

Bartlett's K-squared

Df

p-value

Day 2

64.668

27

6.244e-05

Day 4

61.542

27

0.000165

Day 6

65.862

27

4.278e-05

Table 2 Shapiro-Wilk normality test for days measured (carbon sources). As can be
seen by the p-values in Table 2 the null hypothesis of the Shapiro-Wilk test, that the
data are normally distributed, was rejected for all 3 day intervals.
Day

W

P-value

27

Day 2

0.60523

1.09e-13

Day 4

0.7233

2.755e-11

Day 6

0.63567

4.006e-13

Table 3 Kruskal-Wallis H test for days measured (carbon sources). As can be seen
in Table 3, the null was rejected for all 3 day intervals. Therefore, the samples came
from different distributions.
Day

Chi-squared

Df

P-value

Day 2

78.216

27

7.018e-07

Day 4

68.984

27

1.564e-05

Day 6

78.216

27

7.018e-07

Table 4 Dunn's Many-To-One Test for days measured (carbon sources). For day 2
maltose (p <.05), glucose (p <.05), and dextrin (p <.05) were significantly different
from the control. In day 4 maltose (p <.05) and glucose (p <.05) were significantly
different from the control. For day 6 maltose (p <.05), glucose (p <.05), and dextrin
(p <.05) were significantly different from the control.
Day

Carbon Source

Z value

Pr(>|z|)

Day 2

Glucose

3.423

0.0161097 *

Day 4

Glucose

3.205

0.035083*

Day 6

Glucose

3.423

0.0161097 *

Day 2

Fructose

2.226

0.4941041

Day 4

Fructose

2.176

0.591247

Day 6

Fructose

2.226

0.4941041
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Day 2

Mannose

2.854

0.0950399 .

Day 4

Mannose

1.239

1

Day 6

Mannose

2.854

0.0950399

Day 2

Rhamnose

0.569

1

Day 4

Rhamnose

0.77

1

Day 6

Rhamnose

0.569

1

Day 2

Sorbose

0.301

1

Day 4

Sorbose

0.234

1

Day 6

Sorbose

0.301

1

Day 2

Fucose

-0.075

1

Day 4

Fucose

0.569

1

Day 6

Fucose

Day 2

Galactose

0.41

1

Day 4

Galactose

0.075

1

Day 6

Galactose

0.410

1

Day 2

Arabinose

1.364

1

Day 4

Arabinose

1.431

1

Day 6

Arabinose

1.364

1

Day 2

Xylose

1.657

1

Day 4

Xylose

1.054

1

Day 6

Xylose

1.657

1

Day 2

Ribose

0.603

1

Day 4

Ribose

0.176

1

-0.075

1
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Day 6

Ribose

0.603

1

Day 2

Glycerol

2.619

0.1849404

Day 4

Glycerol

2.619

0.202562

Day 6

Glycerol

2.619

0.1849404

Day 2

Mannitol

0.912

1

Day 4

Mannitol

0.695

1

Day 6

Mannitol

0.912

1

Day 2

A.Acid

2.988

0.0646495 .

Day 4

A.Acid

2.795

0.124482

Day 6

A.Acid

2.988

0.0646495 .

Day 2

G.Acid

0.318

1

Day 4

G.Acid

-0.427

1

Day 6

G.Acid

0.318

1

Day 2

NAG

1.188

1

Day 4

NAG

1.774

1

Day 6

NAG

1.188

1

Day 2

GlcN

-0.494

1

Day 4

GlcN

-0.711

1

Day 6

GlcN

-0.494

1

Day 2

S.Acid

0.753

1

Day 4

S.Acid

0.661

1

Day 6

S.Acid

0.753

1

Day 2

Cellobiose

2.184

0.5209431
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Day 4

Cellobiose

2.31

0.438875

Day 6

Cellobiose

2.184

0.520943

Day 2

Lactose

1.013

1

Day 4

Lactose

0.862

1

Day 6

Lactose

1.013

1

Day 2

Lactulose

1.783

1

Day 4

Lactulose

1.414

1

Day 6

Lactulose

1.783

1

Day 2

Sucrose

2.553

0.2138951

Day 4

Sucrose

2.126

0.637049

Day 6

Sucrose

2.553

0.2138951

Day 2

Trehalose

1.9

0.9194708

Day 4

Trehalose

1.598

1

Day 6

Trehalose

1.900

0.9194708

Day 2

Maltose

3.574

0.0095096 **

Day 4

Maltose

3.356

0.021358*

Day 6

Maltose

3.574

0.0095096 **

Day 2

Starch

3.071

0.0511355 .

Day 4

Starch

2.954

0.078368 .

Day 6

Starch

3.071

0.0511355 .

Day 2

Dextrin

3.256

0.0282976 *

Day 4

Dextrin

2.393

0.367151

Day 6

Dextrin

3.256

0.0282976 *
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Day 2

Raffinose

2.067

0.6582873

Day 4

Raffinose

1.557

1

Day 6

Raffinose

2.067

0.6582873

Day 2

C.Acids

0.1

1

Day 4

C.Acids

0.117

1

Day 6

C.Acids

0.100

1

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1

Media
The null hypothesis of the Bartlett’s test, that the groups had equal variances,
was rejected. This was the case for the data in the media experiments (Table 5 and
9). In addition, the assumption of normality was violated for ANOVA as determined
by the Shapiro-Wilk Test for Normality (Table 6 and 10). The null of the KruskalWallis H test was rejected for each 2 day interval and therefore the samples did not
come from the same distribution (Table 7). Dunn’s many-to-one showed which
specific conditions were different from the control (Table 12).
A total of 6 different media were tested in M. pneumoniae M129-B7. The
media were tested with and without the addition of glucose. The optical density of
the Hayflick -glucose control bacterial population grew 697% between day 0 and day
6. The optical density of the Hayflick -glucose control bacterial population grew
6597% between day 0 and day 6. The control for these two experiments is Hayflick
with glucose and Hayflick without glucose. The growth trends of media without the
addition of glucose were compared via growth curves (Figure 10). Growth trends of
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media with glucose were compared as well (Figure 11). In addition, growth trends of
individual media with and without glucose were compared directly with their controls
(Figure 12, 13, 14, 15, 16, 17). These individual media graphs allow clearer
comparison of growth and view of error bars.
For media grown without added glucose, Mueller Hinton II and Nutrient broth
showed poor growth on some days as seen by growth dips where the lines can no
longer be seen (i.e. day 2 for NB, day 4 and 6 for MHII) (Figure 10). Statistical
analysis showed that none of the media were significantly different from the control.
Dunn’s many-to-one test for Nutrient broth (p= 0.1219, 0.5698, 0.9439), Mueller
Hinton II broth (p= 0.6163, 0.2471, 0.4527), Brain Heart Infusion (p= 0.1219, 1,
0.9439), Lysogeny Broth (p= 0.8945, 1, 1), Tryptic Soy Broth (p= 0.6163, 1, 1), and
Dulbecco’s Modified Eagle’s Medium (p= 0.8146, 0.5894, 0.4527) on days 2, 4, and
6, respectively. The optical density of the BHI, LB, TSB, and DMEM bacterial
populations between days 0 and 6 grew 170%, 430%, 917%, and 14367%,
respectively. However, the optical density of the NB and MHII bacterial populations
between days 0 and 6 decreased by 57% and 100%, respectively. In addition, we
can see that by day 2 bacteria grown on DMEM, HF, or LB have reached their
maximum and stay at stable ODs for days 2 through 6.
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Fig. 10 Media without glucose. Statistical analysis showed that none of the media
were significantly different from the control. The Kruskal–Wallis tests detected
significant differences among the different media groups for days
2 (χ2 = 17.763, df = 6, P < 0.01), 4 (χ2 = 19.189, df = 6, P < 0.01), and 6
(χ2 = 19.662, df = 6, P < 0.01).
For media grown with added glucose, Mueller Hinton II broth showed the
poorest growth on days 2 and 6 (Figure 11). Statistical analysis showed MHII was
significantly different from the control for days 4 and 6. Dunn’s many-to-one test for
Nutrient broth (p= 0.7511, 0.1492, 0.1492), Mueller Hinton II broth (p= 0.1064,
0.0183, 0.0183), Brain Heart Infusion (p= 0.4983, 0.1933, 0.1933), Lysogeny Broth
(p= 1, 1, 1), Tryptic Soy Broth (p= 1, 0.7084, 0.7084), and Dulbecco’s Modified
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Eagle’s Medium (p= 0.7511, 1, 1) on days 2, 4, and 6, respectively. The optical
density of the NB, BHI, LB, TSB, and DMEM bacterial populations between days 0
and 6 grew 90%, 80%, 1770%, 1247%, and 13994%, respectively. However, the
optical density of the MHII bacterial population between days 0 and 6 decreased by
120%. In addition, we can see that by day 2 bacteria grown on DMEM has reached
its maximum and stays at stable ODs for days 2 through 6.

Fig. 11 Media with glucose. Statistical analysis showed MHII was significantly
different from the control for days 4 and 6. The Kruskal–Wallis tests detected
significant differences among the different media groups for days
2 (χ2 = 17.763, df = 6, P < 0.01), 4 (χ2 = 19.189, df = 6, P < 0.01), and 6
(χ2 = 19.662, df = 6, P < 0.01).
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Brain Heart Infusion is a general purpose medium used for the growth of
fastidious and non-fastidious organisms. Statistical analysis showed that Brain Heart
Infusion with or without added glucose was not significantly different from the
control.

Fig. 12 Brain Heart Infusion. Statistical analysis showed that Brain Heart Infusion
with or without added glucose was not significantly different from the control. The
Kruskal–Wallis tests detected significant differences among the different media
groups for days 2 (χ2 = 17.763, df = 6, P < 0.01), 4 (χ2 = 19.189, df = 6, P < 0.01),
and 6 (χ2 = 19.662, df = 6, P < 0.01).
DMEM is a defined medium used to grow mammalian cell cultures. Statistical
analysis showed that DMEM with or without glucose was not significantly different
from the control. By day 2 both DMEM with and without glucose seem to plateau and
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reach stable O.D’s. The optical density for DMEM with glucose and DMEM without
glucose grew 13994% and 14367%, respectively. Though the percent difference is
quite similar DMEM without glucose showed the slightly higher percent difference in
growth between day 0 and day 6. The addition of glucose seemed to have affected
the control more than DMEM whose lines appear very similar. A notable observation
in the experiment related to growth in media revealed that M. pneumoniae does not
adhere to the culture flask when grown in DMEM, the mammalian cell culture
medium. This observation is unexpected since it has been generally believed that
adherence of M. pneumoniae is required for its growth.

Fig. 13 Dulbecco’s Modified Eagle’s Medium. Statistical analysis showed that
DMEM with or without glucose was not significantly different from the control. The
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Kruskal–Wallis tests detected significant differences among the different media
groups for days 2 (χ2 = 17.763, df = 6, P < 0.01), 4 (χ2 = 19.189, df = 6, P < 0.01),
and 6 (χ2 = 19.662, df = 6, P < 0.01).
Lysogeny broth is a nutrient-rich medium used for the growth of many
bacterial organisms. Statistical analysis showed that LB with or without glucose was
not significantly different from the control. By day 2 LB without glucose seems to
plateau and reach stable O.D’s. The same occurred to LB with glucose on day 4.
The optical density for LB with glucose and LB without glucose grew 1770% and
430%, respectively. The addition of glucose positively affected the growth of this
organism when grown in LB. A very similar growth trend can be seen between LB
without glucose and Hayflick without glucose.

Fig. 14 Growth curves conducted on M. pneumoniae using LB media. Statistical
analysis showed that LB with or without glucose was not significantly different from
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the control.
Mueller Hinton II broth is used to quantitatively test the susceptibility of
different bacteria to a variety of antimicrobial agents. Statistical analysis showed
that MHII with added glucose for days 4 and 6 were significantly different from the
control. The optical density for MHII with glucose and MHII without glucose
decreased by 120% and 100%, respectively. These percent differences are very
similar meaning glucose addition hardly affected growth in this medium. Day 2 for
MHII with glucose probably had O.D.s closer to the MHII without glucose yet due to
human error a dip was seen on this day. MHII medium saw the poorest growth of all
media tested.

Fig. 15 Growth curves conducted on M. pneumoniae using MHII media. The
Kruskal–Wallis tests detected significant differences among the different media
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groups for days 2 (χ2 = 17.763, df = 6, P < 0.01), 4 (χ2 = 19.189, df = 6, P < 0.01),
and 6 (χ2 = 19.662, df = 6, P < 0.01).
NB is a general purpose growth medium used for the cultivation of nonfastidious bacteria. Statistical analysis showed that NB with or without glucose was
not significantly different from the control. The optical density for NB with glucose
and NB without glucose grew by 90% and decreased by 57%, respectively. The
addition of glucose positively affected the growth of this organism when grown in
NB, however, there was not a great increase. However, even with the addition of
glucose NB had smaller O.D. values than seen in the control without the addition of
glucose.

Fig. 16 Nutrient Broth. Growth curves conducted on M. pneumoniae using NB
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media. The Kruskal–Wallis tests detected significant differences among the different
media groups for days 2 (χ2 = 17.763, df = 6, P < 0.01), 4
(χ2 = 19.189, df = 6, P < 0.01), and 6 (χ2 = 19.662, df = 6, P < 0.01).
Tryptic Soy Broth is a complex, general purpose growth medium used for the
growth fastidious and non-fastidious bacteria. Statistical analysis showed that TSB
with or without glucose was not significantly different from the control. The optical
density for TSB with glucose and TSB without glucose grew by 1247% and 917%,
respectively. These percent differences are very similar meaning glucose addition
hardly affected growth in this medium. Day 2 showed a large error bar for TSB
without glucose; this large variability is probably caused by human error during
harvesting of cells.
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Fig. 17 Tryptic Soy Broth. Growth curves conducted on M. pneumoniae using TSB
media. The Kruskal–Wallis tests detected significant differences among the different
media groups for days 2 (χ2 = 17.763, df = 6, P < 0.01), 4
(χ2 = 19.189, df = 6, P < 0.01), and 6 (χ2 = 19.662, df = 6, P < 0.01).

Table 5 Bartlett test of homogeneity of variances for days measured (media -glc). As
can be seen by the p-values in Table 5 the null hypothesis of the Bartlett’s test, that
the samples have equal variances, was rejected for all 3 day intervals.
Day

Bartlett's K-squared

Df

p-value

Day 2

75.041

6

3.764e-14

Day 4

25.766

6

0.0002461

Day 6

38.132

6

1.059e-6

Table 6 Shapiro-Wilk normality test for days measured (media -glc).
As can be seen by the p-values in Table 6 the null hypothesis of the Shapiro-Wilk
test, that the data are normally distributed, was rejected for all 3 day intervals for
media with no glucose.
Day

W

P-value

Day 2

0.47134

1.119e-07

Day 4

0.49665

1.895e-07

Day 6

0.56815

9.234e-07
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Table 7 Kruskal-Wallis H test for days measured (media -glc). The Kruskal-Wallis H
Test determines whether samples came from the same distribution. The null
hypothesis of this test is that the mean ranks of the groups are the same. As can be
seen in Table 7, the null was rejected for all 3 day intervals.

Day

Chi-squared

Df

P-value

Day 2

17.763

6

0.006852

Day 4

19.189

6

0.003856

Day 6

19.662

6

0.00318

Table 8 Dunn's many-to-one test for days measured (media –glc). For media
without no added glucose there were no media that showed a statistically difference
from the control as seen in Table 8.
Day

Media w/no glucose

Z value

Pr(>|z|)

Day 2

NB- HF (no glc)

-2.32

0.12197

Day 4

NB- HF (no glc)

-1.581

0.56982

Day 6

NB- HF (no glc)

-1.185

0.94394

Day 2

MHII- HF (no glc)

-1.359

0.61631

Day 4

MHII- HF (no glc)

-2.042

0.24712

Day 6

MHII- HF (no glc)

-1.778

0.45279

Day 2

BHI- HF (no glc)

-2.32

0.12197

Day 4

BHI- HF (no glc)

-0.922

1.00000

Day 6

BHI- HF (no glc)

1.185

0.94394
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Day 2

LB- HF (no glc)

-0.133

0.89452

Day 4

LB- HF (no glc)

-0.066

1.00000

Day 6

LB- HF (no glc)

-0.593

1.00000

Day 2

TSB- HF (no glc)

-1.425

0.61631

Day 4

TSB- HF (no glc)

0.856

1.00000

Day 6

TSB- HF (no glc)

0.593

1.00000

Day 2

DMEM- HF (no glc)

0.829

0.81460

Day 4

DMEM- HF (no glc)

1.449

0.58946

Day 6

DMEM- HF (no glc)

1.778

0.45279

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1
Table 9 Bartlett test of homogeneity of variances days measured (media +glc). As
can be seen by the p-values in Table 9 the null hypothesis of the Bartlett’s test, that
the samples have equal variances, was rejected for all 3 day intervals.
Day

Bartlett's K-squared

Df

p-value

Day 2

60.845

6

3.03e-11

Day 4

20.387

6

0.002363

Day 6

27.551

6

.0001141

Table 10 Shapiro-Wilk normality test for days measured (media +glc). As can be seen
by the p-values in Table 10 the null hypothesis of the Shapiro-Wilk test, that the data
are normally distributed, was rejected for all 3 day intervals for media with added
glucose.
Day

W

P-value
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Day 2

0.46964

1.081e-07

Day 4

0.67054

1.208e-05

Day 6

0.70212

2.926e-05

Table 11 Kruskal-Wallis H test for days measured (media +glc). The Kruskal-Wallis
H Test determines whether samples came from the same distribution. As can be
seen in Table 11, the null was rejected for all 3 day intervals for media with glucose.
Day

Chi-squared

Df

P-value

Day 2

19.432

6

0.003493

Day 4

19.337

6

0.00363

Day 6

19.337

6

0.00363

Table 12 Dunn's many-to-one test for days measured (media +glc). For media
added glucose there were some media which showed a statistically significant
difference from the control. For day 4 and 6, MHII with added glucose showed a
statistically significant difference from the control as seen by the p-values in Table
12.
Day

Media w/ glucose

Z value

Pr(>|z|)

Day 2

NB- HF

-1.317

0.75110

Day 4

NB- HF

-2.172

0.149299

Day 6

NB- HF

-2.172

0.149299

Day 2

MHII- HF

-2.371

0.10646

Day 4

MHII- HF

-2.962

0.018354 *

Day 6

MHII- HF

-2.962

0.018354 *
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Day 2

BHI- HF

-1.646

0.49832

Day 4

BHI- HF

-1.974

0.193301

Day 6

BHI- HF

-1.974

0.193301

Day 2

LB- HF

0.593

1.00000

Day 4

LB- HF

-0.592

1.00000

Day 6

LB- HF

-0.592

1.000000

Day 2

TSB- HF

-0.593

1.00000

Day 4

TSB- HF

-1.185

0.708411

Day 6

TSB- HF

-1.185

0.708411

Day 2

DMEM- HF

1.185

0.75110

Day 4

DMEM- HF

0.592

1.000000

Day 6

DMEM- HF

0.592

1.000000

Signif. codes: 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1

In order to see different trends, additional analysis was conducted. A Principal
Component Analysis (PCA) plot was used to show the correlation among the
different conditions tested into a 2-D graph (Figure 18, 19, 20). Conditions that are
highly correlated will cluster closer together. We obtained the eigenvalues for the
two major components in the PCA. In this case, eigenvalues explain how much the
rotation of the axis had to be changed in order to perform PCA.
For Figure 18, the control is included (Hayflick with not added carbon source).
The four clusters produced are color-coded. Each dot represents the average of day
2, 4, and 6 for each carbon source. Each cluster shows carbon sources which had
similar optical densities. Maltose and glucose (blue) have clustered together and
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therefore show greater correlation to themselves than to the other carbon sources.
This cluster also shows the greatest difference from the control. Dextrin, starch, and
ascorbic acid (purple) have also clustered into another group and are therefore more
similar to each other than the other carbon sources. The other 22 carbon sources
have clustered close to the control. The axes are ranked in order of importance with
the first principal component axis (PC1) showing the largest variation and the
second principal component axis (PC2) showing the second largest variation.
Maltose, dextrin, and glucose affected the PC1 axis the most. Glucose, dextrin, and
maltose affected the PC2 axis the most. The eigenvalues for PC1 and PC2 are
2.330762e-03 and 7.953291e-05, respectively.
For Figure 19, the control is included (Hayflick with added glucose). The four
clusters produced are color-coded. Each dot represents the average of day 2, 4, and
6 for each medium with added glucose. Each cluster shows media which had similar
optical densities. DMEM (blue) and HF (green) have clustered individually while the
rest have clustered into the remaining two groups. HF with glucose affected the PC1
axis the most, while DMEM affected the PC2 axis the most. The eigenvalues for
PC1 and PC2 are 1.084573e-03 and 1.504704e-04, respectively.
For Figure 20, the control is included (Hayflick without added glucose). The
four clusters produced are color-coded. Each dot represents the average of day 2, 4,
and 6 for each medium without added glucose. Each cluster shows media which had
similar optical densities. DMEM (blue) clustered by itself and showed the greatest
difference to all the other media. The rest of the media clustered into 2 very close
clusters which shows they are not very different from each other. DMEM without
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added glucose affected the PC1 axis the most, while TSB without added glucose
affected the PC2 axis the most. The eigenvalues for PC1 and PC2 are 7.704912e05 and 2.738836e-05, respectively.
PCA Plot of Carbon Sources

Fig. 18 Principal Component Analysis plot of all carbon sources. Maltose, dextrin,
and glucose affected the PC1 axis the most. Glucose, dextrin, and maltose affected
the PC2 axis the most. The eigenvalues for PC1 and PC2 are 2.330762e-03 and
7.953291e-05, respectively.
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PCA Plot of Media with Glucose

Fig. 19 Principal Component Analysis plot of media with added glucose. HF with
glucose affected the PC1 axis the most, while DMEM affected the PC2 axis the
most. The eigenvalues for PC1 and PC2 are 1.084573e-03 and 1.504704e-04,
respectively.
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PCA Plot of Media without Glucose

Fig. 20 Principal Component Analysis plot of media without added glucose. DMEM
without added glucose affected the PC1 axis the most, while TSB without added
glucose affected the PC2 axis the most. The eigenvalues for PC1 and PC2
are 7.704912e-05 and 2.738836e-05, respectively.
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DISCUSSION
Mycoplasma pneumoniae was grown in modified Hayflick media containing
different carbon sources; out of these 27 chosen carbon sources only 11 have been
previously tested [33,60,61,62,63,64]. Mycoplasma pneumoniae is often described
as having limited metabolic abilities, however, due to the number of hypothetical and
moonlighting proteins present there is a possibility of unexplored metabolic
pathways. Our growth data shows that M. pneumoniae is able to utilize glucose,
maltose, and dextrin.
Glucose concentration in the lung environment is tightly regulated to curtail
the growth of pathogenic organisms [22]. However, glucose concentrations rise in
the airway surface liquid during airway inflammation and when the patient is
hyperglycemic [72]. The genes involved in glucose metabolism have been found in
M. pneumoniae, however, the genes involved in maltose and dextrin metabolism
have not.
Maltose is composed of two glucose monomers joined by an α (1→4)
glycosidic bond which requires an alpha-glucosidase for its breakdown; once broken
down the two β-D-glucopyranose molecules produced can enter glycolysis. Dextrin
contains glucose polymers linked by α(1→4) and α(1→6) glycosidic bonds. Maltose
and dextrin can both be found in the oropharynx and intestines as products of starch
breakdown (or glycogen breakdown in intestines). Maltose has also been found in
human cervical mucus [73]. However, there is no mention of maltose or dextrin
within the lung environment when reviewing the literature.
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Mycoplasma pneumoniae along with other Mycoplasma spp., have been
shown to possess alpha-glucosidase activity, however, the presence of this protein
has not been proven [74]. Mycoplasma mycoides subsp. capri (Mmc), contains gene
clusters which function in the metabolism of starch, glycogen, and maltose; these
genes share homology with genes found in Bacillus, Listeria, Lactococcus, M.
mobile, and M. pulmonis [75]. The genes in the clusters included: a
phosphoglucomutase, amylases, two lipoproteins, three genes (malC, malG, malK)
encoding a translocation complex, a maltose phosphorylase (mapA), a hypothetical
protein with transmembrane segments, an oligo 1, 6 glycosidase (dexA), and a
transcription regulator [75]. These are functions we would assume M. pneumoniae to
have since this species of Mycoplasma is related and we have shown that M.
pneumoniae can utilize maltose and dextrin.
The results of one study revealed that pulmonary surfactant protein D (SP-D),
which is involved in host defense within the lungs, is able to bind to glycolipids on
the surface of M. pneumoniae; this binding, however, was inhibited by the addition of
carbohydrates, such as maltose, which SP-D would recognize [76]. Another study
showed that the addition of oligosaccharides (e.g. maltose) containing α- or β-(1→4)
linkages contributed to glycoconjugate synthesis in M. pneumoniae [77]. The
addition of maltose but not that of glucose increased the relative abundance of
glucose in the glycoconjugates [77]. The glycocalyx and lipoproteins on the
bacteria’s cell surface incorporate oligosaccharides from the host environment which
likely camouflages them from the host’s immune system [78].
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The control for the carbon source experiment is growth of M. pneumoniae in
Modified Hayflick media with no added carbon source. Any carbon source which
produced greater growth than the control was considered to be metabolized by the
organism. The results of this study coincide with previously reported findings,
however, many carbon sources which are actually metabolized by M. pneumoniae,
as shown in other studies, were not found to be significantly different from the
control. This may be due to the number of replicates conducted for the study and
the diminished power of the statistical tests performed (due to the data not fulfilling
statistical assumptions). Therefore, it is possible that the 16 previously untested may
contain carbon sources that can be indeed be metabolized by M. pneumoniae.
Ascorbic acid, which showed no statistically significant difference from the
control in this experiment, is metabolized by this organism [50]. Mycoplasma
pneumoniae M129 contains genes which code for PTS system ascorbate-specific
transporter subunits. A metabolic map shows ascorbate can be modified and enter
the pentose phosphate pathway where it can lead to the production of RNA or enter
other pathways [62]. A notable observation in this experiment revealed a dull, chalky
cell pellet when ascorbic acid was used as opposed to glossy and mucoid one,
which was seen in all other conditions when scraped cells were centrifuged. Due to
the physical changes seen, we believe the biofilm of these organisms has been
altered due to the addition of ascorbic acid. Mycoplasma pneumoniae, along with
several other species, is able to produce a biofilm [79]. It has been previously
demonstrated that low levels of ascorbic acid can destabilize biofilms and impair
bacterial quorum sensing [80]. This study also revealed that when ascorbic acid is
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added to antibiotics a synergistic effect occurs. Ascorbic acid is believed to limit
synthesis of exopolysaccharides and key proteins involved in biofilm formation. It
would be interesting to evaluate different antibiotics with the addition of ascorbic acid
to see if any synergistic changes occur which could lead to better treatment options.
It would also be interesting to test different strains of M. pneumoniae considering
that the M129 and UAB PO1 strains form different types of biofilms with different
levels of robustness [81].
A total of 6 different media were tested in M. pneumoniae M129-B7. From
these, MHII broth was statistically different from the Hayflick control. MHII media, as
stated in BD documentation, is utilized for the study of antimicrobial agents on gram
positive and gram negative aerobic bacteria. The media consists of beef extract,
acid hydrolysate of casein, starch, calcium and magnesium. Horse serum provides
cholesterol and a protein source. The OD values for M. pneumoniae grown on MHII
were close to zero; this could be due to the low thymine and thymidine content of the
media and the limited biosynthetic ability of this organism.
As mentioned previously, another notable observation in the experiment
related to growth in media revealed that M. pneumoniae does not adhere to the
culture flask when grown in DMEM. This behavior is unexpected since it has been
generally believed that adherence of M. pneumoniae is required for its growth. This
defined media (Table 1) is utilized to grow various adherent cell phenotypes
including: primary fibroblasts, neurons, glial cells, and smooth muscle cells.
Mycoplasma pneumoniae usually attaches to the surface of polystyrene flasks used
when growing this organism in liquid media [82]. Adhesion of M. pneumoniae to
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polystyrene flasks or glass has been suggested to occur through the P1 adhesin
proteins in the apical attachment organ [83]. This study also implied that M.
pneumoniae is interacting with sialic acid residues contained in the horse serum
glycoproteins which attach to the polystyrene surface. DMEM, as all media in these
experiments, was grown with added horse serum, yet the bacteria did not attach to
the flask. With this information, we can conclude that a component within DMEM is
preventing attachment of the P1 adhesins to the sialic acid-containing glycoproteins
within the horse serum. Further tests can look at effects to M. pneumoniae
attachment by testing individual components from DMEM inside HF media.
In conclusion, the aim of our research was to grow this organism in various
conditions to understand which metabolic pathways could be present in this minimal
organism. The next steps would be to grow this organism in maltose and dextrin and
determine protein profiles using SDS-PAGE. The gel bands can then be examined
through mass spec to determine proteins found. Gene knockout studies can be
carried out to determine exact function. It would be interesting to evaluate if the
addition of ascorbic acid alters MICs of M. pneumoniae tested with different
antibiotics. In regards to the media, additional testing can be done by adding
thymidine to the MHII media to see if growth is positively affected. In addition, more
about this organism’s attachment can be learned by testing which of the components
in DMEM is affecting adhesion of M. pneumoniae to the culture flask. Lastly,
differential gene expression of the transcriptome can be analyzed to understand
more about the common metabolic pathways affected by exposure to different
stressors.

55

References
1.

2.
3.

4.

5.

6.

7.
8.

9.
10.

11.

12.
13.

14.

15.

Marston BJ. Incidence of Community-Acquired Pneumonia Requiring
Hospitalization: Results of a Population-Based Active Surveillance Study in
Ohio. Arch Intern Med. 1997;157.
Nisar N, Guleria R, Kumar S, Chand Chawla T, Ranjan Biswas N. Mycoplasma
pneumoniae and its role in asthma. Postgrad Med J. 2007;83: 100–104.
Yimenicioğlu S, Yakut A, Ekici A, Bora Carman K, Cagrı Dinleyici E.
Mycoplasma pneumoniae infection with neurologic complications. Iran J Pediatr.
2014;24: 647–651.
Martínez-Cano DJ, Reyes-Prieto M, Martínez-Romero E, Partida-Martínez LP,
Latorre A, Moya A, et al. Evolution of small prokaryotic genomes. Front
Microbiol. 2014;5: 742.
Großhennig S, Schmidl SR, Schmeisky G, Busse J, Stülke J. Implication of
glycerol and phospholipid transporters in Mycoplasma pneumoniae growth and
virulence. Infect Immun. 2013;81: 896–904.
Himmelreich R, Hilbert H, Plagens H, Pirkl E, Li BC, Herrmann R. Complete
sequence analysis of the genome of the bacterium Mycoplasma pneumoniae.
Nucleic acids Res. 1996;24: 4420–4449.
Waites KB, Talkington DF. Mycoplasma pneumoniae and Its Role as a Human
Pathogen. Clin Microbiol Rev. 2004;17.
Dandekar T, Huynen M, Regula JT, Ueberle B, Zimmermann CU, Andrade MA,
et al. Re-annotating the Mycoplasma pneumoniae genome sequence: adding
value, function and reading frames. Nucleic acids Res. 2000;28: 3278–3288.
Chaudhry R, Varshney AK, Malhotra P. Adhesion proteins of Mycoplasma
pneumoniae. Front Biosci : J Virtual Libr. 2007;12: 690–699.
Krivan HC, Olson LD, Barile MF, Ginsburg V, Roberts DD. Adhesion of
Mycoplasma pneumoniae to sulfated glycolipids and inhibition by dextran
sulfate. J Biol Chem. 1989;264: 9283–9288.
Kannan TR, Provenzano D, Wright JR, Baseman JB. Identification and
characterization of human surfactant protein A binding protein of Mycoplasma
pneumoniae. Infect Immun. 2004;73: 2828–34.
Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human
pathogen. Clin Microbiol Rev. 2004;17: 697–728, table of contents.
Halbedel S, Hames C, Stülke J. Regulation of carbon metabolism in the
mollicutes and its relation to virulence. J Mol Microbiol Biotechnol. 2006;12:
147–154.
Ramasamy K, Balasubramanian S, Manickam K, Pandranki L, Taylor AB, Hart
PJ, et al. Community-Acquired Respiratory Distress Syndrome Toxin Uses a
Novel KELED Sequence for Retrograde Transport and Subsequent Cytotoxicity.
mBio. 2018;9.
Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of

56

16.

17.

18.
19.
20.
21.
22.

23.
24.

25.

26.

27.

28.

29.
30.

31.

Mycoplasma pneumoniae represents unique virulence determinant among
bacterial pathogens. Proc Natl Acad Sci United States Am. 2005;103: 6724–9.
Großhennig S, Ischebeck T, Gibhardt J, Busse J, Feussner I, Stülke J.
Hydrogen sulfide is a novel potential virulence factor of Mycoplasma
pneumoniae: characterization of the unusual cysteine desulfurase/desulfhydrase
HapE. Mol Microbiol. 2016;100: 42–54.
HAYFLICK L, STINEBRING WR. Intracellular growth of pleuropneumonialike
organisms (PPLO) in tissue culture and in ovo. Ann New York Acad Sci.
1960;79: 433–449.
Rottem S. Interaction of mycoplasmas with host cells. Physiol Rev. 2002;83:
417–32.
Winner F, Rosengarten R, Citti C. In vitro cell invasion of Mycoplasma
gallisepticum. Infect Immun. 2000;68: 4238–4244.
Yavlovich A, Higazi AA, Rottem S. Plasminogen binding and activation by
Mycoplasma fermentans. Infect Immun. 2001;69: 1977–1982.
Yavlovich A. Internalization and intracellular survival of Mycoplasma
pneumoniae by non-phagocytic cells. FEMS Microbiol Lett. 2004;233.
Garnett JP, Baker EH, Baines DL. Sweet talk: insights into the nature and
importance of glucose transport in lung epithelium. Eur Respir J. 2012;40:
1269–1276.
Veldhuizen R, Nag K, Orgeig S, Possmayer F. The role of lipids in pulmonary
surfactant. Biochim et Biophys Acta. 1998;1408: 90–108.
Schmidl SR, Otto A, Lluch-Senar M, Piñol J, Busse J, Becher D, et al. A trigger
enzyme in Mycoplasma pneumoniae: impact of the glycerophosphodiesterase
GlpQ on virulence and gene expression. PLoS Pathog. 2011;7: e1002263.
Lee J-W, Helmann JD. Functional specialization within the Fur family of
metalloregulators. Biometals : Int J role Met ions Biol Biochem Med. 2007;20:
485–499.
Fillat MF. The FUR (ferric uptake regulator) superfamily: Diversity and versatility
of key transcriptional regulators. Arch Biochem Biophys. Elsevier; 2013;546: 41–
52.
Ricci S, Janulczyk R, Björck L. The regulator PerR is involved in oxidative stress
response and iron homeostasis and is necessary for full virulence of
Streptococcus pyogenes. Infect Immun. 2002;70: 4968–4976.
Suvorova IA, Korostelev YD, Gelfand MS. GntR Family of Bacterial
Transcription Factors and Their DNA Binding Motifs: Structure, Positioning and
Co-Evolution. PloS one. 2015;10: e0132618.
Hoskisson PA, Rigali S. Chapter 1: Variation in form and function the helix-turnhelix regulators of the GntR superfamily. Adv Appl Microbiol. 2008;69: 1–22.
Liang H, Li L, Dong Z, Surette MG, Duan K. The YebC family protein PA0964
negatively regulates the Pseudomonas aeruginosa quinolone signal system and
pyocyanin production. J Bacteriol. 2008;190: 6217–6227.
Johnson LN, Barford D. The effects of phosphorylation on the structure and

57

function of proteins. Annu Rev Biophys Biomol Struct. 1992;22: 199–232.
32. Schmidl SR, Gronau K, Pietack N, Hecker M, Becher D, Stülke J. The
phosphoproteome of the minimal bacterium Mycoplasma pneumoniae: analysis
of the complete known Ser/Thr kinome suggests the existence of novel kinases.
Mol & Cell proteomics : MCP. 2010;9: 1228–1242.
33. Halbedel S, Busse J, Schmidl SR, Stülke J. Regulatory protein phosphorylation
in Mycoplasma pneumoniae. A PP2C-type phosphatase serves to
dephosphorylate HPr(Ser-P). J Biol Chem. 2006;281: 26253–26259.
34. Halbedel S, Hames C, Stülke J. In vivo activity of enzymatic and regulatory
components of the phosphoenolpyruvate:sugar phosphotransferase system in
Mycoplasma pneumoniae. J Bacteriol. 2004;186: 7936–7943.
35. Jordan JL, Berry KM, Balish MF, Krause DC. Stability and subcellular
localization of cytadherence-associated protein P65 in Mycoplasma
pneumoniae. J Bacteriol. 2001;183: 7387–7391.
36. He J, Liu M, Ye Z, Tan T, Liu X, You X, et al. Insights into the pathogenesis of
Mycoplasma pneumoniae (Review). Mol Med reports. 2016;14: 4030–4036.
37. Schmidl SR, Gronau K, Hames C, Busse J, Becher D, Hecker M, et al. The
stability of cytadherence proteins in Mycoplasma pneumoniae requires activity
of the protein kinase PrkC. Infect Immun. 2010;78: 184–192.
38. Batut B, Knibbe C, Marais G, Daubin V. Reductive genome evolution at both
ends of the bacterial population size spectrum. Nat Rev Microbiol. 2014;12:
841–850.
39. Koskiniemi S, Sun S, Berg OG, Andersson DI. Selection-driven gene loss in
bacteria. PLoS Genet. 2012;8: e1002787.
40. Cavalier-Smith T. Economy, speed and size matter: evolutionary forces driving
nuclear genome miniaturization and expansion. Ann Bot. Oxford University
Press; 2004;95: 147–75.
41. Moran NA, Plague GR. Genomic changes following host restriction in bacteria.
Curr Opin Genet & Dev. 2004;14: 627–633.
42. Song H, Hwang J, Yi H, Ulrich RL, Yu Y, Nierman WC, et al. The early stage of
bacterial genome-reductive evolution in the host. PLoS Pathog. 2010;6:
e1000922.
43. Dutow P, Schmidl SR, Ridderbusch M, Stülke J. Interactions between glycolytic
enzymes of Mycoplasma pneumoniae. J Mol Microbiol Biotechnol. 2010;19:
134–139.
44. Menard L, Maughan D, Vigoreaux J. The structural and functional coordination
of glycolytic enzymes in muscle: evidence of a metabolon? Biology. 2014;3:
623–644.
45. Campanella ME, Chu H, Low PS. Assembly and regulation of a glycolytic
enzyme complex on the human erythrocyte membrane. Proc Natl Acad Sci
United States Am. 2005;102: 2402–2407.
46. Mowbray J, Moses V. The tentative identification in Escherichia coli of a
multienzyme complex with glycolytic activity. Eur J Biochem. Wiley Online
Library; 1975;66: 25–36.

58

47. Commichau FM, Rothe FM, Herzberg C, Wagner E, Hellwig D, Lehnik-Habrink
M, et al. Novel activities of glycolytic enzymes in Bacillus subtilis: interactions
with essential proteins involved in mRNA processing. Mol & Cell proteomics :
MCP. 2009;8: 1350–1360.
48. Gründel A, Pfeiffer M, Jacobs E, Dumke R. Network of Surface-Displayed
Glycolytic Enzymes in Mycoplasma pneumoniae and Their Interactions with
Human Plasminogen. Infect Immun. 2015;84: 666–676.
49. Castellino FJ, Ploplis VA. Structure and function of the plasminogen/plasmin
system. Thromb Haemost. 2005;93: 647–654.
50. Wodke JAH, Puchałka J, Lluch-Senar M, Marcos J, Yus E, Godinho M, et al.
Dissecting the energy metabolism in Mycoplasma pneumoniae through
genome-scale metabolic modeling. Mol Syst Biol. 2012;9: 653.
51. Kennedy JF, Knill CJ. Glycoscience—chemistry and chemical biology I–III.
Carbohydr Polym. 2003;54.
52. Himmelreich R, Plagens H, Hilbert H, Reiner B, Herrmann R. Comparative
analysis of the genomes of the bacteria Mycoplasma pneumoniae and
Mycoplasma genitalium. Nucleic acids Res. 1997;25: 701–712.
53. Blötz C, Stülke J. Glycerol metabolism and its implication in virulence in
Mycoplasma. FEMS Microbiol Rev. 2017;41: 640–652.
54. Klement MLR, Ojemyr L, Tagscherer KE, Widmalm G, Wieslander A. A
processive lipid glycosyltransferase in the small human pathogen Mycoplasma
pneumoniae: involvement in host immune response. Mol Microbiol. 2007;65:
1444–1457.
55. Nir-Paz R, Saraya T, Shimizu T, Van Rossum A, Bébéar C, editors.
Mycoplasma pneumoniae Clinical Manifestations, Microbiology, and
Immunology. Frontiers Media SA; 2016.
56. Wang L, Hames C, Schmidl SR, Stülke J. Upregulation of thymidine kinase
activity compensates for loss of thymidylate synthase activity in Mycoplasma
pneumoniae. Mol Microbiol. 2010;77: 1502–1511.
57. Kashyap S, Sarkar M. Mycoplasma pneumonia: Clinical features and
management. Lung India : Off Organ Indian Chest Soc. 2010;27: 75–85.
58. Pachkov M, Dandekar T, Korbel J, Bork P, Schuster S. Use of pathway analysis
and genome context methods for functional genomics of Mycoplasma
pneumoniae nucleotide metabolism. Gene. 2007;396: 215–225.
59. Balish MF, Distelhorst SL. Potential Molecular Targets for Narrow-Spectrum
Agents to Combat Mycoplasma pneumoniae Infection and Disease. Front
Microbiol. 2016;7: 205.
60. Sun R, Wang L. Inhibition of Mycoplasma pneumoniae growth by FDA-approved
anticancer and antiviral nucleoside and nucleobase analogs. BMC Microbiol.
2013;13: 184.
61. Hames C, Halbedel S, Hoppert M, Frey J, Stülke J. Glycerol metabolism is
important for cytotoxicity of Mycoplasma pneumoniae. J Bacteriol. 2009;191:
747–753.
62. Yus E, Maier T, Michalodimitrakis K, van Noort V, Yamada T, Chen W-H, et al.

59

63.

64.
65.
66.

67.

68.

69.
70.

71.
72.
73.
74.

75.

76.

77.

78.

Impact of genome reduction on bacterial metabolism and its regulation. Sci.
2009;326: 1263–1268.
Jordan DS, Daubenspeck JM, Dybvig K. Rhamnose biosynthesis in
mycoplasmas requires precursor glycans larger than monosaccharide. Mol
Microbiol. 2013;89: 918–928.
HAYFLICK L, CHANOCK RM. MYCOPLASMA SPECIES OF MAN. Bacteriol
Rev. 1965;29: 185–221.
Low IE, Eaton MD, Proctor P. Relation of catalase to substrate utilization by
Mycoplasma pneumoniae. J Bacteriol. 1968;95: 1425–1430.
Folmsbee M, Howard G, McAlister M. Nutritional effects of culture media on
mycoplasma cell size and removal by filtration. Biol : J Int Assoc Biol Stand.
2010;38: 214–217.
CHANOCK RM, HAYFLICK L, BARILE MF. Growth on artificial medium of an
agent associated with atypical pneumonia and its identification as a PPLO. Proc
Natl Acad Sci United States Am. 1962;48: 41–49.
Loginova LI, Manuilova VP, Tolstikov VP. Content of free amino acids in
peptone and the dynamics of their consumption in the microbiological synthesis
of dextran. Pharm Chem J. 1974;8.
Chen JK, Shen CR, Liu CL. N-acetylglucosamine: Production and applications.
Mar Drugs. 2009;8: 2493–2516.
Lim YZ, Hussain SM, Cicuttini FM, Wang Y. Nutrients and Dietary Supplements
for Osteoarthritis. Bioactive Food as Dietary Interventions for Arthritis and
Related Inflammatory Diseases. Elsevier; 2018. pp. 97–137.
Pendarvis R. Essentials of Carbohydrate Chemistry by John F. Robyt. Chem
Educ. 1998;3.
Baker EH, Baines DL. Airway Glucose Homeostasis: A New Target in the
Prevention and Treatment of Pulmonary Infection. Chest. 2018;153: 507–514.
BRECKENRIDGE MAB, POMMERENKE WT. Analysis of carbohydrates in
human cervical mucus. Fertil Steril. 1951;2: 29–44.
Kahane I, Reisch-Saada A, Almagor M, Abeliuck P, Yatziv S. Glycosidase
activities of mycoplasmas. Zentralblatt fur Bakteriol : Int J Med Microbiol.
1990;273: 300–305.
Thiaucourt F, Manso-Silvan L, Salah W, Barbe V, Vacherie B, Jacob D, et al.
Mycoplasma mycoides, from “mycoides Small Colony” to “capri”. A
microevolutionary perspective. BMC Genomic-. 2011;12: 114.
Chiba H, Pattanajitvilai S, Evans AJ, Harbeck RJ, Voelker DR. Human
surfactant protein D (SP-D) binds Mycoplasma pneumoniae by high affinity
interactions with lipids. J Biol Chem. 2002;277: 20379–20385.
Daubenspeck JM, Jordan DS, Simmons W, Renfrow MB, Dybvig K. General Nand O-Linked Glycosylation of Lipoproteins in Mycoplasmas and Role of
Exogenous Oligosaccharide. PloS one. 2015;10: e0143362.
Mollicutes: Molecular Biology and Pathogenesis. Edited by Glenn F. Browning
and Christine Citti. Norfolk (United Kingdom): Caister Academic Press. 319.00. x

60

79.

80.

81.

82.
83.

+ 333 p. + 6 pl.; ill.; index. ISBN: 978-1-908230-30-0. 2014. Q Rev Biol.
2015;90.
Feng M, Schaff AC, Cuadra Aruguete SA, Riggs HE, Distelhorst SL, Balish MF.
Development of Mycoplasma pneumoniae biofilms in vitro and the limited role of
motility. Int J Med Microbiol : IJMM. 2018;308: 324–334.
Pandit S, Ravikumar V, Abdel-Haleem AM, Derouiche A, Mokkapati VRSS,
Sihlbom C, et al. Low Concentrations of Vitamin C Reduce the Synthesis of
Extracellular Polymers and Destabilize Bacterial Biofilms. Front Microbiol.
2017;8: 2599.
Simmons WL, Daubenspeck JM, Osborne JD, Balish MF, Waites KB, Dybvig K.
Type 1 and type 2 strains of Mycoplasma pneumoniae form different biofilms.
Microbiol. 2013;159: 737–747.
Taylor-Robinson D, Manchee RJ. Adherence of mycoplasmas to glass and
plastic. J Bacteriol. 1967;94: 1781–1782.
Kornspan JD, Tarshis M, Rottem S. Adhesion and biofilm formation of
Mycoplasma pneumoniae on an abiotic surface. Arch Microbiol. 2011;193: 833–
836.

61

VITA
Maria Guadalupe Hinojosa
3052 S. Louisiana Ave.
Laredo, TX 78046
maria.ghinojosa@gmail.com
956-3335286
RESEARCH INTERESTS
Microbiology, Cell biology, Bacterial pathogenesis
EDUCATION
MS in Biology (January 2017-Present) – TEXAS A&M INTERNATIONAL
UNIVERSITY, Laredo, TX
BS in Biology (August 2010-December 2014) – THE UNIVERSITY OF TEXAS AT
SAN ANTONIO, San Antonio, TX
LEADERSHIP
Research Mentor, Texas A&M International University, January 2018-December
2018
SACNAS Historian, The University of Texas at San Antonio, January 2012December 2012
UTSA Ambassador in training, The University of Texas at San Antonio, August
2010-January 2011
RESEARCH ACTIVITIES
 GRADUATE RESEARCH STUDENT, Texas A&M International University,
Analyzed growth of M. pneumoniae when exposed to different carbon
sources, PI: Dr. Sebastian Schmidl, August 2016-Present
 UNDERGRADUATE INDEPENDENT STUDY, Measured anthocyanin
concentration of Arabidopsis thaliana,The University of Texas at San Antonio,
PI: Dr. Valerie Sponsel, January 2014-December 2014
 MINORITY BIOMEDICAL RESEARCH SUPPORT AND RESEARCH
INITIATIVE FOR SCIENTIFIC ENHANCEMENT RESEARCH STUDENT,
Protein purification of BB0019, PI: Dr. Janakiram Seshu, June 2013December 2013
HONORS
Awarded the Terry Foundation Scholarship to outstanding high school graduates.
2010

